These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 32296135)

  • 1. COVID-19: risk for cytokine targeting in chronic inflammatory diseases?
    Schett G; Sticherling M; Neurath MF
    Nat Rev Immunol; 2020 May; 20(5):271-272. PubMed ID: 32296135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of immune activation with methotrexate in patients with COVID-19.
    Safavi F; Nath A
    J Neurol Sci; 2020 Aug; 415():116942. PubMed ID: 32471659
    [No Abstract]   [Full Text] [Related]  

  • 3. Inflammatory cytokines, T lymphocyte subsets, and ritonavir involved in liver injury of COVID-19 patients.
    Liao S; Zhan K; Gan L; Bai Y; Li J; Yuan G; Cai Y; Zhang A; He S; Mei Z
    Signal Transduct Target Ther; 2020 Oct; 5(1):255. PubMed ID: 33130825
    [No Abstract]   [Full Text] [Related]  

  • 4. Secondary hemophagocytic lymphohistiocytosis, HScore and COVID-19.
    Loscocco GG
    Int J Hematol; 2020 Jul; 112(1):125-126. PubMed ID: 32474804
    [No Abstract]   [Full Text] [Related]  

  • 5. Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19.
    Takami A
    Int J Hematol; 2020 Jul; 112(1):122-124. PubMed ID: 32399895
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporine therapy in cytokine storm due to coronavirus disease 2019 (COVID-19).
    Cure E; Kucuk A; Cumhur Cure M
    Rheumatol Int; 2020 Jul; 40(7):1177-1179. PubMed ID: 32415310
    [No Abstract]   [Full Text] [Related]  

  • 7. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
    Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
    Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of coronavirus disease 2019 (COVID-19) in cancer patients with prior exposure to immune checkpoint inhibitors.
    Wu Q; Chu Q; Zhang H; Yang B; He X; Zhong Y; Yuan X; Chua MLK; Xie C
    Cancer Commun (Lond); 2020 Aug; 40(8):374-379. PubMed ID: 32666636
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19 as a cause of immune thrombocytopenia.
    Humbert S; Razanamahery J; Payet-Revest C; Bouiller K; Chirouze C
    Med Mal Infect; 2020 Aug; 50(5):459-460. PubMed ID: 32445664
    [No Abstract]   [Full Text] [Related]  

  • 10. Kidney involvement in COVID-19 and rationale for extracorporeal therapies.
    Ronco C; Reis T
    Nat Rev Nephrol; 2020 Jun; 16(6):308-310. PubMed ID: 32273593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency.
    Isidori AM; Arnaldi G; Boscaro M; Falorni A; Giordano C; Giordano R; Pivonello R; Pofi R; Hasenmajer V; Venneri MA; Sbardella E; Simeoli C; Scaroni C; Lenzi A
    J Endocrinol Invest; 2020 Aug; 43(8):1141-1147. PubMed ID: 32335855
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm.
    Mahmoudi S; Rezaei M; Mansouri N; Marjani M; Mansouri D
    J Clin Immunol; 2020 Oct; 40(7):974-976. PubMed ID: 32648027
    [No Abstract]   [Full Text] [Related]  

  • 13. The allergist/immunologist, the Janus gatekeeper of inflammation, COVID-19 and beyond.
    Bellanti JA; Settipane RA
    Allergy Asthma Proc; 2020 Nov; 41(6):395-396. PubMed ID: 33109305
    [No Abstract]   [Full Text] [Related]  

  • 14. Thoughts on COVID-19 and autoimmune diseases.
    Askanase AD; Khalili L; Buyon JP
    Lupus Sci Med; 2020; 7(1):e000396. PubMed ID: 32341791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clozapine prescription in the wake of the coronavirus (SARS CoV-2) outbreak: What measures? Why?].
    Ben Dhia A; Hamzaoui S; Mouaffak F
    Encephale; 2020 Jun; 46(3S):S123-S124. PubMed ID: 32317164
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytokine storm and use of anakinra in a patient with COVID-19.
    Nemchand P; Tahir H; Mediwake R; Lee J
    BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32933914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion.
    Simon D; Tascilar K; Krönke G; Kleyer A; Zaiss MM; Heppt F; Meder C; Atreya R; Klenske E; Dietrich P; Abdullah A; Kliem T; Corte G; Morf H; Leppkes M; Kremer AE; Ramming A; Pachowsky M; Schuch F; Ronneberger M; Kleinert S; Maier C; Hueber AJ; Manger K; Manger B; Berking C; Tenbusch M; Überla K; Sticherling M; Neurath MF; Schett G
    Nat Commun; 2020 Jul; 11(1):3774. PubMed ID: 32709909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Interleukin-6 in Lung Complications in Patients With COVID-19: Therapeutic Implications.
    Smetana K; Brábek J
    In Vivo; 2020 Jun; 34(3 Suppl):1589-1592. PubMed ID: 32503815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical course of COVID-19 in 41 patients with immune-mediated inflammatory diseases: Experience from humanitas center, Milan.
    Allocca M; Guidelli GM; Borroni RG; Selmi C; Narcisi A; Danese S; Fiorino G
    Pharmacol Res; 2020 Oct; 160():105061. PubMed ID: 32629021
    [No Abstract]   [Full Text] [Related]  

  • 20. Pulmonary Artery Embolism in COVID-19 Despite Thrombosis Prophylaxis.
    Geerdes-Fenge HF; Reisinger EC; Arndt H
    Dtsch Arztebl Int; 2020 Apr; 117(17):297. PubMed ID: 32530413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.